Advertisement

Topics

Light Sciences Oncology, Inc. Company Profile

11:09 EDT 25th September 2017 | BioPortfolio

Light Sciences Oncology (LSO) is developing Aptocine for solid tumors as well as benign neoplasms including benign prostatic hyperplasia (BPH). Besides the Phase 3 trials of Aptocine in HCC and MCRC, LSO is also conducting clinical trials of Aptocine in patients with BPH and in neurofibromatosis, and has clinical or preclinical programs for the Aptocine platform in cardiovascular, ophthalmic, and dermatologic diseases. The company has positioned itself with a strong portfolio of intellectual property, innovative applications in development, and an exceptionally capable and efficient team.


PubMed Articles [4009 Associated PubMed Articles listed on BioPortfolio]

Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.

Older adults compose the majority of patients with cancer in the United States; however, it is unclear how well geriatrics or geriatric oncology training is being incorporated into hematology-oncology...

Controversies in management of low-grade gliomas in light of new data from clinical trials.

Immunotherapy: Shining light on immune-based mechanisms.

Immune oncology and neuroendocrine tumors.

Antiproliferative activity of 8-methoxypsoralen on DU145 prostate cancer cells under UVA and blue light.

The use of photoactivatable 8-methoxypsoralen (8-MOP) as potential focal treatment towards prostate cancer cells is proposed here. Our results, obtained on isolated DNA and DU145 cells, indicate that ...

Clinical Trials [1376 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

The purpose of the study is to assess the survival of patients treated with Litx™ versus standard of care therapies in the treatment of unresectable hepatocellular carcinoma (HCC), and t...

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

The purpose of the study is to assess the progression free survival and overall survival of patients treated with Litx™ + chemotherapy versus chemotherapy alone in the treatment of Color...

Light Therapy to Increase Energy in Adolescents With Solid Tumors: A Pilot Study

Fatigue is one of the most consistent and distressing symptoms reported by pediatric oncology patients. The investigators' work has demonstrated that in the period from diagnosis through t...

Study to Evaluate the Safety and Efficacy of a Low Level Light Device in Patients With Knee Osteoarthritis

This Phase I study is being conducted to examine the efficacy of the Light Sciences LLC (LSLLC) phototherapy device for home (self) treatment of knee osteoarthritis (OA).

Lung Registry for Lung Cancer Patients That They Have Been Referred to a Tertiary Oncology Unit

In the light of the new era in the management of lung cancer we are proposing a non-interventional study which will capture all the epidemiological, clinical, pathological, molecular and t...

Companies [1911 Associated Companies listed on BioPortfolio]

Light Sciences Oncology, Inc.

Light Sciences Oncology (LSO) is developing Aptocine for solid tumors as well as benign neoplasms including benign prostatic hyperplasia (BPH). Besides the Phase 3 trials of Aptocine in HCC and MCRC, ...

Light Sciences, corporation

Light Sciences' Light Infusion Technology™ (Litx™) platform is designed to create a transformation in the clinical use of photodynamic therapy by providing treatment solutions for patients with ca...

Miravant Medical Technologies

Miravant Medical Technologies, formerly PDT, Inc., is engaged in the integrated development of drugs and medical device products for use in PhotoPoint(TM), their proprietary technolo...

EBS

Energy Beam Sciences designs, manufactures, and sells quality products for histology, light microscopy, electron microscopy, materials sciences, and the production, control and application of electron...

Rainbow Light® Nutritional Systems, Inc.

Rainbow Light Nutritional Systems, a leader in natural nutrition since 1981, is best known for its number one selling natural Just Once® multivitamin line. Rainbow Light's Bio-balanced formulas are b...

More Information about "Light Sciences Oncology, Inc." on BioPortfolio

We have published hundreds of Light Sciences Oncology, Inc. news stories on BioPortfolio along with dozens of Light Sciences Oncology, Inc. Clinical Trials and PubMed Articles about Light Sciences Oncology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Light Sciences Oncology, Inc. Companies in our database. You can also find out about relevant Light Sciences Oncology, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...


Corporate Database Quicklinks



Searches Linking to this Company Record